The Patent Finder

TorreyPines Therapeutics

Also on record
Records under this name other than patents TorreyPines Therapeutics holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 5 of 5 · Back to TorreyPines Therapeutics

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,244,739Compounds and uses thereof in modulating amyloid beta
Formerly held
Term ended
Term ended Mar 21, 2025 · USPTO record
Term endedTerm ended Mar 21, 2025USPTO record
US 7,781,442Compounds and uses thereof in modulating amyloid beta
Formerly held
Term ended
Term ended Nov 10, 2024 · USPTO record
Term endedTerm ended Nov 10, 2024USPTO record
US 7,645,588Composition Comprising a Cell Comprising a STIM1 Protein and an Agent That Modulates Intracellular Calcium and Methods of Use
Formerly held
Term ended
Term ended Mar 29, 2024 · High confidence
Term endedTerm ended Mar 29, 2024High confidence
US 6,495,700Process for producing phenserine and its analog
Term ended
Term ended Jan 9, 2022 · USPTO record
Term endedTerm ended Jan 9, 2022USPTO record
US 7,799,808α-Haloketone derivatives of imidazolyl-substituted aromatic compounds and compounds prepared therefrom
Formerly held
Lapsed on the fee record
Ended Sep 21, 2018 · USPTO record
Lapsed on the fee recordEnded Sep 21, 2018USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited